ID: ALA4103073

Max Phase: Preclinical

Molecular Formula: C11H9ClN4O

Molecular Weight: 248.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(NC(=O)c2cncnc2)ccc1Cl

Standard InChI:  InChI=1S/C11H9ClN4O/c1-7-9(12)2-3-10(15-7)16-11(17)8-4-13-6-14-5-8/h2-6H,1H3,(H,15,16,17)

Standard InChI Key:  REQHWDHGCYPELB-UHFFFAOYSA-N

Associated Targets(non-human)

MDCK-II 565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.67Molecular Weight (Monoisotopic): 248.0465AlogP: 2.09#Rotatable Bonds: 2
Polar Surface Area: 67.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.53CX Basic pKa: 1.77CX LogP: 1.25CX LogD: 1.25
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.88Np Likeness Score: -1.89

References

1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH..  (2017)  Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.,  27  (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063]

Source